Oramed Pharmaceuticals, Inc. (ORMP)
4.62
-0.05
(-1.07%)
USD |
NASDAQ |
Sep 15, 16:00
4.625
0.00 (0.00%)
After-Hours: 20:00
Oramed Pharmaceuticals Price to Book Value : 0.6012 for Sept. 15, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 15, 2026 | 0.6012 |
| September 14, 2026 | 0.6077 |
| September 11, 2026 | 0.6064 |
| September 10, 2026 | 0.6194 |
| September 09, 2026 | 0.622 |
| September 08, 2026 | 0.6481 |
| September 04, 2026 | 0.652 |
| September 03, 2026 | 0.6416 |
| September 02, 2026 | 0.6598 |
| September 01, 2026 | 0.6312 |
| August 31, 2026 | 0.6533 |
| August 28, 2026 | 0.6546 |
| August 27, 2026 | 0.6637 |
| August 26, 2026 | 0.6949 |
| August 25, 2026 | 0.678 |
| August 24, 2026 | 0.6272 |
| August 21, 2026 | 0.6259 |
| August 20, 2026 | 0.6233 |
| August 19, 2026 | 0.6233 |
| August 18, 2026 | 0.622 |
| August 17, 2026 | 0.5947 |
| August 14, 2026 | 0.583 |
| August 13, 2026 | 0.57 |
| August 12, 2026 | 0.5557 |
| August 11, 2026 | 0.5531 |
| Date | Value |
|---|---|
| August 10, 2026 | 0.5466 |
| August 07, 2026 | 0.5596 |
| August 06, 2026 | 0.5596 |
| August 05, 2026 | 0.5622 |
| August 04, 2026 | 0.5804 |
| August 03, 2026 | 0.5713 |
| July 31, 2026 | 0.5296 |
| July 30, 2026 | 0.5362 |
| July 29, 2026 | 0.5166 |
| July 28, 2026 | 0.5427 |
| July 27, 2026 | 0.5414 |
| July 24, 2026 | 0.5244 |
| July 23, 2026 | 0.5414 |
| July 22, 2026 | 0.5231 |
| July 21, 2026 | 0.5231 |
| July 20, 2026 | 0.5336 |
| July 17, 2026 | 0.5244 |
| July 16, 2026 | 0.527 |
| July 15, 2026 | 0.5283 |
| July 14, 2026 | 0.5205 |
| July 13, 2026 | 0.5147 |
| July 10, 2026 | 0.5257 |
| July 09, 2026 | 0.544 |
| July 08, 2026 | 0.5583 |
| July 07, 2026 | 0.5596 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 31.57 |
| Pfizer Inc. | 1.843 |
| Liquidia Corp. | 30.01 |
| NRX Pharmaceuticals, Inc. | -- |
| Scilex Holding Co. | -- |
Price to Book Value Related Metrics
| PE Ratio | 1.124 |
| Price | 4.62 |
| Earnings Yield | 88.97% |
| Market Cap | 190.87M |
| Normalized PE Ratio | 4.407 |